TARGETING OF MYC BY HDAC INHIBITION IN MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA

被引:0
|
作者
Ecker, Jonas [1 ,2 ,3 ,4 ]
Oehme, Ina [1 ,2 ]
Selt, Florian [1 ,2 ,3 ,4 ]
Kool, Marcel [2 ,5 ]
Chavez, Lukas [2 ,5 ]
Hohloch, Juliane [1 ,2 ]
Valinciute, Gintvile [1 ,2 ]
van Tilburg, Cornelis M. [3 ,4 ]
Schnolzer, Martina [6 ]
Warnken, Uwe [6 ]
Wechsler-Reya, Robert [7 ]
Pfister, Stefan M. [2 ,3 ,4 ,5 ]
Witt, Olaf [1 ,2 ,3 ,4 ]
Milde, Till [1 ,2 ,3 ,4 ]
机构
[1] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
[3] German Canc Res Ctr, Ctr Individualized Pediat Oncol ZIPO & Brain Tumo, Translat Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[4] German Canc Co, Heidelberg, Germany
[5] German Canc Res Ctr, Div Pediat Neurooncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[6] German Canc Res Ctr, Funct Proteome Anal B100, Heidelberg, Germany
[7] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MEDU-20
引用
收藏
页码:41 / 42
页数:3
相关论文
共 50 条
  • [41] A CASE OF GROUP 3 MEDULLOBLASTOMA WITH HETEROGENEOUS MYC AMPLIFICATION AND POOR OUTCOME
    Irikura, Tomoya
    Fukuoka, Kohei
    Kanemura, Yonehiro
    Hirato, Junko
    Yoshioka, Takako
    Tanami, Yutaka
    Kurihara, Jun
    Oya, Soichi
    Nakazawa, Atsuko
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [42] IDENTIFICATION OF NOVEL EPIGENETIC DRUG COMBINATIONS WITH SYNERGISTIC INHIBITORY EFFECTS AGAINST MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
    Zhang, Lei
    Li, Meng
    Sui, Yi
    Liu, Fang
    Jiang, Wenyan
    Li, Tiantian
    Tang, Yujie
    NEURO-ONCOLOGY, 2017, 19 : 193 - 193
  • [43] Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
    Gintvile Valinciute
    Jonas Ecker
    Florian Selt
    Thomas Hielscher
    Romain Sigaud
    Johannes Ridinger
    Venu Thatikonda
    Charlotte Gatzweiler
    Sarah Robinson
    Julie Talbot
    Flavia Bernardi
    Daniel Picard
    Mirjam Blattner-Johnson
    Simone Schmid
    David T. Jones
    Cornelis M. van Tilburg
    David Capper
    Marcel Kool
    Marc Remke
    Ina Oehme
    Stefan M. Pfister
    Martine F. Roussel
    Olivier Ayrault
    Olaf Witt
    Till Milde
    Journal of Neuro-Oncology, 2023, 163 : 143 - 158
  • [44] Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
    Valinciute, Gintvile
    Ecker, Jonas
    Selt, Florian
    Hielscher, Thomas
    Sigaud, Romain
    Ridinger, Johannes
    Thatikonda, Venu
    Gatzweiler, Charlotte
    Robinson, Sarah
    Talbot, Julie
    Bernardi, Flavia
    Picard, Daniel
    Blattner-Johnson, Mirjam
    Schmid, Simone
    Jones, David T.
    van Tilburg, Cornelis M.
    Capper, David
    Kool, Marcel
    Remke, Marc
    Oehme, Ina
    Pfister, Stefan M.
    Roussel, Martine F.
    Ayrault, Olivier
    Witt, Olaf
    Milde, Till
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (01) : 143 - 158
  • [45] A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
    Kling, Matthew J.
    Kesherwani, Varun
    Mishra, Nitish K.
    Alexander, Gracey
    McIntyre, Erin M.
    Ray, Sutapa
    Challagundla, Kishore B.
    Joshi, Shantaram S.
    Coulter, Don W.
    Chaturvedi, Nagendra K.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [46] A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
    Matthew J. Kling
    Varun Kesherwani
    Nitish K. Mishra
    Gracey Alexander
    Erin M. McIntyre
    Sutapa Ray
    Kishore B. Challagundla
    Shantaram S. Joshi
    Don W. Coulter
    Nagendra K. Chaturvedi
    Journal of Experimental & Clinical Cancer Research, 41
  • [47] A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma
    Chaturvedi, Nagendra K.
    Kling, Matthew J.
    Griggs, Connor N.
    Kesherwani, Varun
    Shukla, Mamta
    McIntyre, Erin M.
    Ray, Sutapa
    Liu, Yutong
    McGuire, Timothy R.
    Sharp, J. Graham
    Band, Hamid
    Joshi, Shantaram S.
    Coulter, Don W.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (06) : 1351 - 1362
  • [48] Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma
    Gwynne, William D.
    Suk, Yujin
    Custers, Stefan
    Mikolajewicz, Nicholas
    Chan, Jeremy K.
    Zador, Zsolt
    Chafe, Shawn C.
    Zhai, Kui
    Escudero, Laura
    Zhang, Cunjie
    Zaslaver, Olga
    Chokshi, Chirayu
    Shaikh, Muhammad Vaseem
    Bakhshinyan, David
    Burns, Ian
    Chaudhry, Iqra
    Nachmani, Omri
    Mobilio, Daniel
    Maich, William T.
    Mero, Patricia
    Brown, Kevin R.
    Quaile, Andrew T.
    Venugopal, Chitra
    Moffat, Jason
    Montenegro-Burke, J. Rafael
    Singh, Sheila K.
    CANCER CELL, 2022, 40 (12) : 1488 - +
  • [49] ELUCIDATING MECHANISMS OF ENHANCED OXIDATIVE PHOSPHORYLATION IN MYC-AMPLIFIED MEDULLOBLASTOMA
    Burwag, Fares
    Delaidelli, Alberto
    Yao, Betty
    Negri, Gian Luca
    Huang, Yue Zhou
    Huang, Albert
    Vislovukh, Andrii
    Langman, Sonya
    Hughes, Christopher
    Leprivier, Gabriel
    Sorensen, Poul
    NEURO-ONCOLOGY, 2023, 25
  • [50] Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma
    Gwynne, William D.
    Suk, Yujin Suk
    Custers, Stefan
    Mikolajewicz, Nicholas
    Chan, Jeremy K.
    Zador, Zsolt
    Chafe, Shawn C.
    Zhai, Kui
    Escudero, Laura
    Zhang, Cunjie
    Zaslaver, Olga
    Chokshi, Chirayu
    Shaikh, Muhammad Vaseem
    Bakhshinyan, David
    Burns, Ian
    Chaudhry, Iqra
    Nachmani, Omri
    Mobilio, Daniel
    Maich, William T.
    Mero, Patricia
    Brown, Kevin R.
    Quaile, Andrew T.
    Venugopal, Chitra
    Moffat, Jason
    Montenegro-Burke, J. Rafael
    Singh, Sheila K.
    CANCER RESEARCH, 2023, 83 (07)